16:02 Dec 20
RPG Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
RPG Life Sciences Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
72/100
High Financial Strength
Valuation
22/100
Expensive Valuation
Technical
57/100
Technically Neutral
Strength
9
Weakness
2
Opportunity
1
Threats
0
11.54 %
ROE %
4.05 %
ROA %
42.72
EPS
49.74
BVPS
6.87 %
Net Profit Margin
| Mar 2006 | Mar 2007 | ||
|---|---|---|---|
| Net Sales | 144.3 | 120.29 | |
| Operating Expenses + | 107.98 | 98.04 | |
| Raw Material | 42.42 | 38.85 | |
| Increase Decrease in Cost | 4.15 | 3.08 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 19.4 | 20.58 | |
| Miscellaneous Expenses | 62.67 | 52.83 | |
| Operating Profit | 36.32 | 22.25 | |
| Other Income | 15.69 | 4.03 | |
| Depreciation | 5.58 | 4.76 | |
| Interest | 18.02 | 11.57 | |
| Profit before tax and exceptio.. | 28.41 | 9.94 | |
| Exceptional Items | 0 | 0 | |
| PBT | 28.41 | 9.94 | |
| Provision for Taxation | 2.67 | 1.68 | |
| Net Profit | 25.74 | 8.27 | |
| NET Profit after MI | 25.74 | 8.27 | |
| EPS | 17.89 | 5.74 | |
| Operating Profit Margin (%) | 25.17 | 18.5 | |
| Net Profit Margin (%) | 17.84 | 6.88 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Promoter | 72.80 | 72.80 | 72.80 | 72.80 | 72.80 |
| FII | 1.40 | 1.20 | 0.90 | 0.60 | 0.50 |
| MF | 2.70 | 1.60 | 1.50 | 1.10 | 0.80 |
| Public | 20.40 | 21.40 | 22.10 | 22.80 | 23.10 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Others | 2.70 | 3.00 | 2.70 | 2.70 | 2.70 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
